Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Lühr Hansen, Mathias; Pellicer, Adelina; Gluud, Christian; Dempsey, Eugene; Mintzer, Jonathan; Hyttel-Sørensen, Simon; Marie Heuchan, Anne; Hagmann, Cornelia; Ergenekon, Ebru; Dimitriou, Gabriel; Pichler, Gerhard; Naulaers, Gunnar; Cheng, Guoqiang; Guimarães, Hercilia; Tkaczyk, Jakub; B. Kreutzer, Karen; Fumagalli, Monica; Claris, Olivier; Lemmers, Petra; Fredly, Siv; Szczapa, Tomasz; Austin, Topun; Christian Jakobsen, Janus; Greisen, Gorm

doi:10.1186/s13063-019-3955-6

Public

Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Shared by NobleBlocks on Dec 1, 2019 • 12:00 AM UTC

Authors:

Mathias Lühr Hansen

Adelina Pellicer

Christian Gluud

Abstract

Abstract Background Cerebral oxygenation monitoring may reduce the risk of death and neurologic complications in extremely preterm infants, but no such effects have yet been demonstrated in preterm infants in sufficiently powered randomised clinical trials. The objective of the SafeBoosC III trial i...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!